CGRP family of peptides : IUPHAR Review : ” X ” Running title : Pharmacology of the calcitonin / CGRP family

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases

  2018cited by this paper
• Phase-plate cryo-EM structure of a class B GPCR-G protein complex

  2017cited by this paper
• A novel dual amylin and calcitonin receptor agonist, KBP‐089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference

  2017cited by this paper
• Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.

  2017cited by this paper
• Crystal structure of the GLP-1 receptor bound to a peptide agonist

  2017cited by this paper
• Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog.

  2017cited by this paper
• CGRP and its receptors

  2017cited by this paper
• The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis

  2017cited by this paper
• Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?

  2017cited by this paper
• β-arrestins negatively control human adrenomedullin type 1-receptor internalization.

  2017cited by this paper
• Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms

  2017cited by this paper
• KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight.

  2016cited by this paper
• Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1.

  2016cited by this paper
• Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor

  2016cited by this paper
• Inhibitory effects of two G protein-coupled receptor kinases on the cell surface expression and signaling of the human adrenomedullin receptor.

  2016cited by this paper
• Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography*

  2016cited by this paper
• Amylin structure–function relationships and receptor pharmacology: implications for amylin mimetic drug development

  2016cited by this paper
• Ligand-Dependent Modulation of G Protein Conformation Alters Drug Efficacy.

  2016cited by this paper
• Adrenomedullin 2.0: Adjusting Key Levers for Metabolic Stability.

  2016cited by this paper
• Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

  2016cited by this paper
• Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies.

  2016cited by this paper
• Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles.

  2016cited by this paper
• Amylin: Pharmacology, Physiology, and Clinical Potential

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors

  2015cited by this paper
• CGRP Mechanism Antagonists and Migraine Management

  2015cited by this paper
• Does salmon calcitonin cause cancer? A review and meta-analysis

  2015cited by this paper
• Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor

  2015cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

  2015cited by this paper
• Monoconjugation of Human Amylin with Methylpolyethyleneglycol

  2015cited by this paper
• Convergent chemoenzymatic synthesis of a library of glycosylated analogues of pramlintide: structure-activity relationships for amylin receptor agonism.

  2014cited by this paper
• Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts

  2014cited by this paper
• Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats.

  2014cited by this paper
• Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias

  2014influential reference
• A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats.

  2014influential reference
• Regulation of signal transduction by HDL1

  2013cited by this paper
• Glycosylation of pramlintide: synthetic glycopeptides that display in vitro and in vivo activities as amylin receptor agonists.

  2013cited by this paper
• Analysis of the proteolysis of bioactive peptides using a peptidomics approach

  2013cited by this paper
• The role of glutamic acid 73 in adrenomedullin interactions with rodent AM2 receptors.

  2012cited by this paper
• Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes

  2012influential reference
• The pharmacology of Adrenomedullin 2/Intermedin

  2012cited by this paper
• Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.

  2012influential reference
• Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine

  2012influential reference
• Endosomal proteolysis regulates calcitonin gene‐related peptide responses in mesenteric arteries

  2012cited by this paper
• Oral Salmon Calcitonin Improves Fasting and Postprandial Glycemic Control in Lean Healthy Rats

  2011cited by this paper
• Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight

  2010cited by this paper
• Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism.

  2010cited by this paper
• Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization.

  2010cited by this paper
• Novel Peptide Antagonists of Adrenomedullin and Calcitonin Gene-Related Peptide Receptors: Identification, Pharmacological Characterization, and Interactions with Position 74 in Receptor Activity-Modifying Protein 1/3

  2009cited by this paper
• CGRP receptor antagonists: design and screening

  2009cited by this paper
• Calcitonin receptor-stimulating peptide: Its evolutionary and functional relationship with calcitonin/calcitonin gene-related peptide based on gene structure.

  2009cited by this paper
• Juxtamembranous Region of the Amino Terminus of the Family B G Protein-coupled Calcitonin Receptor Plays a Critical Role in Small-molecule Agonist Action*

  2009cited by this paper
• International Union of Pharmacology. LXIX. Status of the Calcitonin Gene-Related Peptide Subtype 2 Receptor

  2008cited by this paper
• Intermedins A and B; New metabolites from Schisandra propinqua var. intermedia

  2008cited by this paper
• Adrenomedullin-2/Intermedin Induces cAMP Accumulation in Dissociated Rat Spinal Cord Cells: Evidence for the Existence of a Distinct Class of Sites of Action

  2008cited by this paper
• Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema.

  2008cited by this paper
• Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals.

  2008cited by this paper
• Adrenomedullin 2 (AM2)/intermedin is a more potent activator of hypothalamic oxytocin-secreting neurons than AM possibly through an unidentified receptor in rats.

  2007cited by this paper
• Pharmacology of the human CGRP1 receptor in Cos 7 cells.

  2006cited by this paper
• Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms

  2006influential reference
• Determinants of 1-Piperidinecarboxamide, N-[2-[[5-Amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) Affinity for Calcitonin Gene-Related Peptide and Amylin Receptors—The Role of Rec

  2006cited by this paper
• Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.

  2006cited by this paper
• Intermedin/Adrenomedullin-2 inhibits growth hormone release from cultured, primary anterior pituitary cells.

  2006cited by this paper
• Receptor Activity-modifying Protein (RAMP) Isoform-specific Regulation of Adrenomedullin Receptor Trafficking by NHERF-1*[boxs]

  2005cited by this paper
• Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes

  2005cited by this paper
• Novel Function for Receptor Activity-modifying Proteins (RAMPs) in Post-endocytic Receptor Trafficking*♦

  2005cited by this paper
• Identification, structural determination, and biological activity of bovine and canine calcitonin receptor-stimulating peptides.

  2004cited by this paper
• Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator

  2004cited by this paper
• Analysis of the cellular expression pattern of β‐CGRP in α‐CGRP‐deficient mice

  2004influential reference
• Structure and biological properties of three calcitonin receptor-stimulating peptides, novel members of the calcitonin gene-related peptide family.

  2004cited by this paper
• Intermedin Is a Calcitonin/Calcitonin Gene-related Peptide Family Peptide Acting through the Calcitonin Receptor-like Receptor/Receptor Activity-modifying Protein Receptor Complexes*

  2004cited by this paper
• Binding of Filamin to the C-terminal Tail of the Calcitonin Receptor Controls Recycling*

  2003cited by this paper
• Ontogeny of calcitonin receptor mRNA and protein in the developing central nervous system of the rat

  2003cited by this paper
• Calcitonin Receptor-stimulating Peptide, a New Member of the Calcitonin Gene-related Peptide Family

  2003cited by this paper
• Adrenomedullin promotes proliferation and migration of cultured endothelial cells.

  2003cited by this paper
• Salmon calcitonin – a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents

  2002cited by this paper
• International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors

  2002cited by this paper
• A comparison of the actions of BIBN4096BS and CGRP8–37 on CGRP and adrenomedullin receptors expressed on SK‐N‐MC, L6, Col 29 and Rat 2 cells

  2002cited by this paper
• Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat

  2001cited by this paper
• Pharmacology of SB-273779, a nonpeptide calcitonin gene-related peptide 1 receptor antagonist.

  2001cited by this paper
• Expression cloning

  2001influential reference
• Receptor-activity-modifying protein 1 forms heterodimers with two G-protein-coupled receptors to define ligand recognition.

  2000cited by this paper
• Amylin receptors mediate the anorectic action of salmon calcitonin (sCT).

  2000cited by this paper
• Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment.

  2000cited by this paper
• Adrenomedullin, a multifunctional regulatory peptide.

  2000cited by this paper
• An Amylin Receptor Is Revealed Following Co-Transfection of a Calcitonin Receptor with Receptor Activity Modifying Proteins-1 or -3.

  1999cited by this paper
• From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.

  1998cited by this paper
• RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

  1998influential reference
• Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript.

  1995cited by this paper
• CALCITONINS AND OSTEOPOROSIS

  1994cited by this paper
• Pharmacological characterization of a receptor for calcitonin gene‐related peptide on rat, L6 myocytes

  1992cited by this paper
• Comparison of a Calcitonin Gene‐Related Peptide Receptor in a Human Neuroblastoma Cell Line (SK‐N‐MC) and a Calcitonin Receptor in a Human Breast Carcinoma Cell Line (T47D) a

  1992cited by this paper
• Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide.

  1985influential reference

• No citing papers are available for this paper.